Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$21.05 USD
+0.84 (4.16%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $21.00 -0.05 (-0.24%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HIMS 21.05 +0.84(4.16%)
Will HIMS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
3 Companies Set to Positively Surprise this Earnings Season
2 Top-Ranked Cheap Growth Stocks to Buy in July and Hold
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's How Abbott (ABT) is Placed Ahead of Q2 Earnings Release
Hyperfine (HYPR) Inks New Partnerships to Expand in Europe
STERIS (STE) AST Business Expands, New Offerings Aid Growth
Other News for HIMS
Phunware (PHUN) Stock Volatile Ahead of Trump-Biden Debate Tonight
Walgreens Stores Closing: Retailer Announces ‘Imminent’ Changes as WBA Stock Slumps
Short Seller Hunterbrook Slams Hims & Hers (HIMS) Stock in New Report
Hims & Hers down 6% following report on weight loss drug
Hims & Hers down 6% following report on 'shady supplier' for weight loss drug